Pharmacotherapy for Cardiovascular Disorders (Essay Sample)
Review the Resources for this module and consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.
Review the case study assigned by your Instructor for this Assignment.
Select one the following factors: genetics, gender, ethnicity, age, or behavior factors.
Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.
Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.
Think about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient.
Patient AO has a history of obesity and has recently gained 9 pounds. The patient has been diagnosed with hypertension and hyperlipidemia. Drugs currently prescribed include the following:
Atenolol 12.5 mg daily
Doxazosin 8 mg daily
Hydralazine 10 mg qid
Sertraline 25 mg daily
Simvastatin 80 mg daily
Address the folowing:
Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.
Pharmacotherapy for Cardiovascular Disorders
When it comes to medical prescription, the doctor or physician needs to ensure that he or she knows the most effective medication to administer to the patient. To do this, there is a need to know the patient's medical history as well as the current set of drugs that the patient is using. Additionally, all the factors about the patient need to be taken into consideration, such as demographics and any disease history; a process known as comprehensive patient assessment. In this case, it is important to take into consideration the patient's weight history as well as his diagnosis of hypertension and hyperlipidemia. It is important to analyze the patient's behavioral factors.
How pharmacokinetic and pharmacodynamic processes are affected by gender and behavioral factors.
These two processes greatly vary between men and women. According to Franconi and Campesi (2014), women have been found to have more adverse reactions to certain medications compared to men. These reactions are not only adverse but also severe. Behavioral factors, on the other hand, entail quite a lot, but the bottom line is that they are caused mainly by the environment of the caregiver and the patient. As a result, men and women can be taken as two very different specimens when placed in a certain environment, since this would, in turn, impact their behavior or that of the physician.
Similarly, hypertension and hyperlipidemia instances vary greatly between men and women due to their differences in behavior. For patient AO, the fact that there has been a 9-pound increase in weight is an immediate risk factor for hypertension and hyperlipidemia. Hypertension has got various classes. In the case of patient AO, it is clear th
- Consumerism in Health Care PaperDescription: An explanation to what research shows regarding customer perception of health care over the past 5 years....1 page/≈275 words | 2 Sources | APA | Health, Medicine, Nursing | Essay |
- Safety ConcernsDescription: Health and Medicine: Safety Concerns...1 page/≈275 words | 1 Source | APA | Health, Medicine, Nursing | Essay |
- 07-U3-T1-T2: Third-Party Payment, Medicaid and MedicareDescription: How does third-party payment distort the market for health care? If it is so distorted why does every wealthy country insist on using third-party intermediaries to purchase health care?...2 pages/≈550 words | 6 Sources | APA | Health, Medicine, Nursing | Essay |